The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network

The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network is a forecasted federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Center for Advancing Translational Sciences. This initiative builds upon the existing Clinical and Translational Science Awards Program and is designed to strengthen the national infrastructure supporting multi center clinical trials. The Trial Innovation Network serves as a collaborative platform to address inefficiencies and systemic challenges in clinical trial design, execution, and evaluation. By leveraging a coordinated network approach, the program seeks to improve the speed, quality, and cost effectiveness of clinical research across the United States. The primary purpose of this funding opportunity is to advance the science and operational capacity of clinical trials by fostering innovation at both the individual trial level and across trial networks. The program emphasizes the development and implementation of new tools, methodologies, and frameworks that can enhance trial performance. Areas of focus include safety monitoring systems, training and mentorship for clinical trial leaders, integration of digital health technologies, expansion of genomic capabilities, and modeling of disease progression. These focus areas reflect the broader goal of transforming how multi center clinical trials are conducted, ultimately accelerating the translation of research findings into improved patient outcomes. Funding under this opportunity will be provided through a cooperative agreement mechanism, indicating substantial involvement from the funding agency in program oversight and collaboration. While specific funding amounts, ceilings, and floors are not provided in the forecast, the program is expected to support large scale, multi institutional efforts that align with the strategic priorities of the National Center for Advancing Translational Sciences. There is no cost sharing or matching requirement associated with this opportunity, which lowers financial barriers for applicants and encourages broad participation from eligible organizations. Eligibility for this opportunity is extensive and inclusive, encompassing a wide range of entity types. Eligible applicants include state and local governments, nonprofit organizations with and without 501(c)(3) status, federally recognized and non federally recognized tribal governments and organizations, institutions of higher education both public and private, small businesses, for profit organizations, independent school districts, public housing authorities, and other entities such as faith based and community based organizations. Federal agencies, U.S. territories, and regional organizations are also eligible. This broad eligibility framework supports the program’s objective of fostering diverse and collaborative partnerships across sectors. The application process is expected to follow standard NIH submission procedures, although specific submission steps and required components are not detailed in the forecast notice. Applications will be subject to NIH peer review processes, ensuring that only proposals demonstrating strong scientific merit and alignment with program objectives are considered for funding. Applicants should anticipate preparing comprehensive proposals that address innovation, feasibility, and potential impact, as well as their capacity to contribute to a national clinical trial network. The timeline for this opportunity indicates that it is currently in a forecast stage, with an estimated posting date of September 1, 2026. The estimated application due date is January 25, 2027, with awards anticipated to be made by December 15, 2027, and project start dates aligned with the award date. As a forecasted opportunity, these dates are subject to change, and applicants are encouraged to monitor updates from the funding agency. Inquiries regarding the opportunity can be directed to the Division of Clinical Innovation at the National Center for Advancing Translational Sciences via email at tin@nih.gov.